Ikarian Capital’s LYRA THERAPEUTICS INC LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-21,161
| Closed | -$65.2K | – | 191 |
|
|
2025
Q4 | $65.2K | Hold |
21,161
| – | – | 0.01% | 165 |
|
|
2025
Q3 | $139K | Hold |
21,161
| – | – | 0.01% | 158 |
|
|
2025
Q2 | $190K | Sell |
21,161
-2
| -0% | -$17 | 0.04% | 114 |
|
|
2025
Q1 | $134K | Hold |
21,163
| – | – | 0.02% | 147 |
|
|
2024
Q4 | $218K | Buy |
21,163
+26
| +0.1% | +$286 | 0.03% | 150 |
|
|
2024
Q3 | $272K | Hold |
21,137
| – | – | 0.04% | 131 |
|
|
2024
Q2 | $292K | Hold |
21,137
| – | – | 0.05% | 103 |
|
|
2024
Q1 | $6.57M | Sell |
21,137
-3,951
| -16% | -$1.05M | 0.72% | 45 |
|
|
2023
Q4 | $6.57M | Hold |
25,088
| – | – | 0.62% | 55 |
|
|
2023
Q3 | $4.9M | Buy |
25,088
+5,515
| +28% | +$987K | 0.59% | 50 |
|
|
2023
Q2 | $4.02M | Buy |
19,573
+12,699
| +185% | +$1.76M | 0.64% | 47 |
|
|
2023
Q1 | $711K | Hold |
6,874
| – | – | 0.16% | 88 |
|
|
2022
Q4 | $1.08M | Hold |
6,874
| – | – | 0.26% | 48 |
|
|
2022
Q3 | $1.72M | Sell |
6,874
-73
| -1% | -$21.6K | 0.34% | 59 |
|
|
2022
Q2 | $1.96M | Sell |
6,947
-1,500
| -18% | -$408K | 0.36% | 58 |
|
|
2022
Q1 | $1.7M | Buy |
8,447
+556
| +7% | +$122K | 0.22% | 75 |
|
|
2021
Q4 | $1.72M | Sell |
7,891
-178
| -2% | -$57.2K | 0.26% | 72 |
|
|
2021
Q3 | $3.69M | Sell |
8,069
-4,425
| -35% | -$1.67M | 0.26% | 85 |
|
|
2021
Q2 | $5.02M | Sell |
12,494
-3,121
| -20% | -$1.42M | 0.41% | 69 |
|
|
2021
Q1 | $9.05M | Sell |
15,615
-692
| -4% | -$432K | 0.3% | 75 |
|
|
2020
Q4 | $9.29M | Buy |
16,307
+8,548
| +110% | +$4.82M | 0.41% | 58 |
|
|
2020
Q3 | $4.34M | Buy |
+7,759
| New | +$4.82M | 0.31% | 73 |
|
Other funds holding LYRA
Ikarian Capital's LYRA Position: Q1 2026 in Review
Ikarian Capital sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 21,161 shares — an estimated $65.2K sold.
Ikarian Capital first reported a position in LYRA in Q3 2020 and held it in 22 quarters. The position peaked at $9.29M in Q4 2020. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.
- Ikarian Capital reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
- Ikarian Capital sold 21,161 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $65.2K.
- Ikarian Capital first reported a position in LYRA THERAPEUTICS INC in Q3 2020 and held it in 22 quarters.
- Ikarian Capital's LYRA THERAPEUTICS INC position peaked at $9.29M in Q4 2020.
- 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.
Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.